R. Brent Wisner

Supreme Court Rejects Takeda and Eli Lilly Appeal in Actos RICO Case

June 8, 2020, Washington D.C. -- The United States Supreme Court has declined Takeda Pharmaceuticals and Eli Lilly Co.’s appeal of a lawsuit accusing both companies of defrauding patients and health benefit funds by failing to disclose that the diabetes drug Actos increases the risk of developing bladder cancer. Actos [...]

R. Brent Wisner Earns Civil Plaintiff Trial Lawyer of the Year Award

January 30, 2020, Los Angeles, California - - R. Brent Wisner, vice president and senior partner of Baum Hedlund Aristei & Goldman, was named the 2019 Civil Plaintiff Trial Lawyer of the Year by the National Trial Lawyers and ALM for winning a $2 billion verdict in the Monsanto Roundup [...]

By |2020-02-06T10:45:11-08:00January 30th, 2020|Blog, Monsanto Roundup News, Press Releases, R. Brent Wisner|

Ninth Circuit Revives Actos RICO Class Action Against Takeda and Eli Lilly

Dec. 3, 2019 – San Francisco, California - - Takeda Pharmaceuticals Company and Eli Lilly and Company will face revived class action claims after the U.S. Court of Appeals for the Ninth Circuit reversed a Central District of California court decision. The plaintiffs, a Minnesota-based healthcare fund and consumers from multiple [...]

Michael L. Baum and R. Brent Wisner Named to Lawdragon Top 500 List

Oct. 21, 2019 – Los Angeles, California - - Attorneys Michael L. Baum and R. Brent Wisner from the national law firm of Baum, Hedlund, Aristei & Goldman were selected to the Lawdragon 500 Leading Plaintiff Consumer Lawyers list for 2019. Michael Baum, president and managing partner at Baum Hedlund, [...]

By |2019-11-25T16:23:35-08:00October 21st, 2019|Blog, Press Releases, Michael L. Baum, R. Brent Wisner|

Lawsuit Seeks Punitive Damages, Alleges Zantac Drug Makers Knew About NDMA Defect but Failed to Warn or Test

October 21, 2019, Los Angeles, California - -The national law firm of Baum Hedlund Aristei & Goldman has filed lawsuits against the manufacturers of Zantac, alleging the popular heartburn drug leads to the formation of a potent cancer-causing chemical, NDMA, at levels over 3,000 times greater than the Food and [...]

By |2020-06-09T15:30:12-07:00October 21st, 2019|Blog, Pharma News, Press Releases, R. Brent Wisner|

Roundup Attorney R. Brent Wisner | Daily Journal Top 40 Under 40

Aug. 21, 2019 – Los Angeles, California - - R. Brent Wisner, attorney and vice president at the law firm of Baum, Hedlund, Aristei & Goldman, has been selected to the Daily Journal’s Top 40 Under 40 for 2019. In a report published in its August issue, the Daily Journal [...]

By |2020-06-12T16:48:54-07:00August 21st, 2019|Blog, Monsanto Roundup News, Press Releases, R. Brent Wisner|

New Release of Monsanto Documents – Monsanto Papers Part III

Aug. 15, 2019 – Los Angeles, California - - The national law firm of Baum, Hedlund, Aristei & Goldman added 100+ new documents to the Monsanto Papers today. The new Monsanto Papers documents are available for review via the Baum, Hedlund, Aristei & Goldman website. Prior to, during, and after [...]

R. Brent Wisner Recognized as One of the Top Plaintiff Lawyers in California

June 24, 2019 – Los Angeles, California - - The Daily Journal recognized Baum, Hedlund, Aristei & Goldman attorney R. Brent Wisner as one of the Top Plaintiff Lawyers for 2019. The renowned legal publication recognized 30 of the top lawyers in California who brought significant cases in several key areas of practice, [...]

By |2019-06-24T16:03:22-07:00June 24th, 2019|Blog, Monsanto Roundup News, Press Releases, R. Brent Wisner|

Hakluyt Report: White House Has Monsanto’s Back

June 3, 2019 – Los Angeles, California - - At the end of April, the third Roundup cancer trial of Pilliod et al. v. Monsanto Company was nearing its end. The first two trials resulted in landmark defeats for Monsanto (now Bayer). Jury verdicts worth a combined $369 million led to monumental drops in [...]

By |2019-06-06T11:57:32-07:00June 3rd, 2019|Monsanto Roundup News, R. Brent Wisner|

Monsanto Hit with $2 Billion Verdict Losing Third Roundup Trial

May 13, 2019 – Oakland, California - - An Alameda jury in the case of Pilliod et al. v. Monsanto Company (Case No. RG17862702, JCCP No. 4953) returned a verdict today of $2.055 billion in favor of a husband and wife with non-Hodgkin lymphoma, ordering Monsanto to pay $55 million in compensatory damages and $2 billion in punitive [...]